Joseph Magagnoli
Overview
Explore the profile of Joseph Magagnoli including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
54
Citations
620
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Magagnoli J, Knopf K, Hrushesky W, Carson K, Bennett C
Am J Hematol
. 2025 Feb;
PMID: 39935027
Background: Since 2015, ferric carboxymaltose (FCM), an intravenous (IV) iron formulation used for treating iron deficiency anemia (IDA), has been associated with an increasing number of reported hypophosphatemia (HPP) cases....
2.
Pittman R, Sutton S, Magagnoli J, Cummings T
J Comp Eff Res
. 2025 Jan;
14(2):e240187.
PMID: 39836031
To compare the safety and efficacy of antidepressants (AD) among older adults with major depressive disorder (MDD) by assessing treatment change, augmentation and hospitalization rates. This retrospective study analyzed data...
3.
Magagnoli J, Cummings T, Hardin J, Ambati J, Sutton S
Diabetes Obes Metab
. 2024 Nov;
27(2):675-682.
PMID: 39529444
Background: Chronic inflammation is a key factor in type 2 diabetes mellitus (T2DM) development. The cholinergic anti-inflammatory pathway (CAP) reduces inflammation by activating α7 nicotinic acetylcholine receptors (α7nAChRs) on macrophages,...
4.
Magagnoli J, Cummings T, Wyatt M, Shtutman M, Sutton S
J Acquir Immune Defic Syndr
. 2024 Oct;
98(2):133-142.
PMID: 39418469
Background: Comorbidities such as schizophrenia and medication such as antipsychotics may influence the risk of dementia among people living with HIV (PLWH). The objective of this article is to assess...
5.
Bennett C, Magagnoli J, Gundabolu K, Georgantopoulos P, Lebby A, Watson G, et al.
PLoS One
. 2024 Sep;
19(9):e0308205.
PMID: 39321181
Introduction: In May 2022, the Centers for Disease Control and Prevention disseminated an alert advising that "a few" persons with Nirmatrelvir/ritonavir (NM/R)-associated rebound of COVID-19 infection had been identified. Three...
6.
Cummings T, Magagnoli J, Sikirzhytskaya A, Tyagin I, Safro I, Wyatt M, et al.
AIDS
. 2024 Sep;
38(15):1999-2009.
PMID: 39250700
Background: The decreased mortality of people with HIV (PWH) has revealed non-HIV-associated comorbidities such as neurocognitive disorders (e.g., dementia). There is an urgency to discover therapeutics to prevent or delay...
7.
Sutton S, Magagnoli J, Cummings T, Hardin J
Clin Appl Thromb Hemost
. 2024 Aug;
30:10760296241275138.
PMID: 39215507
Objective: This study aimed to investigate the associations between total serum bilirubin levels and the incidence of venous thromboembolism (VTE) among patients with influenza infection. Methods: A retrospective cohort study...
8.
Magagnoli J, Sutton S, Ambati J
JAMA Ophthalmol
. 2024 Jul;
142(8):759-760.
PMID: 38990521
No abstract available.
9.
Magagnoli J, Sutton S, Ambati J
JAMA Ophthalmol
. 2024 May;
142(7):684-685.
PMID: 38722622
No abstract available.
10.
Massey J, Magagnoli J, Sutton S, Buckhaults P, Wyatt M
bioRxiv
. 2024 Apr;
PMID: 38645136
Genome instability is a hallmark of cancer and are driven by mutations in oncogenes and tumor suppressor genes. Despite successes seen with select targeted therapeutics, this type of personalized medicine...